http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-280886-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859cdfebbc1eb9c8ff914d39fa3ef9bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1991-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8075c523c710033c84201e204f1a28c4 |
| publicationDate | 1996-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-280886-B6 |
| titleOfInvention | Ranitidine-based pharmaceutical composition |
| abstract | An effervescent ranitidine pharmaceutical formulation for oral administration is described. The composition comprises ranitidine or a physiologically acceptable salt thereof, preferably ranitidine hydrochloride, alkali metal citrate and an alkali carbonate or bicarbonate, such as alkali metal citrate exclusively containing alkali metal dihydrogen citrate, preferably sodium. In addition, the pharmaceutical composition may comprise a flavoring and / or sweetening agent. The ranitidine content in a single dose of the composition, which is preferably a tablet or powder packaged in sachets is 150 or 300 g. |
| priorityDate | 1988-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.